After 40 consecutive years of reductions in heart attacks and stroke death rates, there has been a worrisome upswing, especially in minority populations. Innovation in new treatments for cardiovascular disease is lagging, and while risk factor modifications could significantly reduce the odds of CVD, a majority of preventable deaths remain attributable to cardiovascular disease. At the same time, access to optimal medical therapies is increasingly influenced by an individual’s economic situation and financial resources.
The Value in Healthcare Initiative aims to bring enterprise-wide solutions and leadership to the urgent issues facing patients.
The Learning Collaboratives
- Read a Perspective from our leaders discussing the Initiative's work
- Read Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative’s Value-Based Models Learning Collaborative
- Read Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation: A Call to Action from the Value in Healthcare Initiative's Predict & Prevent Learning Collaborative
- Read Improving Cardiovascular Drug and Device Development and Evidence through Patient-Centered Research and Clinical Trials: A Call to Action from the Value in Healthcare Initiative's Partnering with Regulators Learning Collaborative
- Read Streamlining and Reimagining Prior Authorization under Value-Based Contracts: A Call to Action from the Value in Healthcare Initiative's Prior Authorization Learning Collaborative